Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Car-t    symbols : NVSEF    save search

Global CAR-T Therapy Pipeline Analysis Market Report 2023: Increasing Financial Support Provided by Different Organizations to Promote Development and Consumption Drives Growth
Published: 2023-04-06 (Crawled : 22:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report pipeline global car-t financial therapy growth market
CAR-T Cell Therapy Market Size to Reach USD 9.62 Million in 2030| Emergen Research
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 twitter stocktwits trandingview |
Health Technology
| | O: 3.03% H: 0.0% C: 0.0%
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 3.12% H: 0.0% C: -2.55%
ALPMY | News | $9.53 -1.11% 690K twitter stocktwits trandingview |
Manufacturing
| | O: 0.58% H: 0.44% C: -0.31%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.26% C: -3.27%
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.27% C: -3.89%
BMY | $48.99 -0.31% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.05% C: -2.89%
BNTX | News | $88.53 0.59% 0.59% 360K twitter stocktwits trandingview |
Health Technology
| | O: 1.42% H: 0.64% C: -2.27%

research car-t therapy market
FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Published: 2022-05-27 (Crawled : 23:00) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

kymriah fda novartis car-t therapy
Novartis receives positive CHMP opinion for Kymriah® CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma in Europe
Published: 2022-03-25 (Crawled : 12:20) - globenewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 1.14% H: 0.0% C: 0.0%

kymriah novartis europe car-t positive therapy chmp t-cell
Novartis announces T-Charge™, next-generation CAR-T platform with first-in-human data at ASH 2021
Published: 2021-12-13 (Crawled : 21:00) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.5% C: -0.43%

novartis car-t platform charging
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
Published: 2021-11-04 (Crawled : 15:15) - globenewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: -0.89%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.28% C: 0.18%
INCY | $51.62 -0.58% -0.58% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 0.0% C: 0.0%

ema car-t platform
Global CAR-T Therapy Pipeline Report 2021: Market is Expected to Stabilize and Reach $6,100 Million in 2030
Published: 2021-10-29 (Crawled : 12:00) - prnewswire.com
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 0.18% C: 0.18%

therapy car-t
Global CAR-T Cell Therapy Markets to 2026: Rising Clinical Trials and Development of New and Effective Therapy Options
Published: 2021-09-28 (Crawled : 16:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490 twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 1.77% C: -0.99%
NVS | News | $97.28 2.27% 0.31% 3.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.16% H: 0.04% C: -0.51%
JNJ | News | $149.56 0.3% 0.0% 9.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.04% H: 0.5% C: -0.18%
ABBV | News | $169.54 0.98% -0.91% 4.1M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 0.93% C: -0.26%
SGMO | News | $0.5212 2.18% 2.13% 2.3M twitter stocktwits trandingview |
Health Technology
| | O: -1.12% H: 0.52% C: -2.17%
AUTL | $4.5 -1.32% -1.33% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: -2.67% H: 1.27% C: -5.48%
AMGN | News | $273.69 0.66% 0.65% 2.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 1.16% C: -0.01%

clinical trials therapy car-t trials trial t-cell
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.